Metabolic Syndrome is Associated With Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation- A National Estimate

被引：0
|
作者：
Patel, Urvish K.
Patel, Priyadarshee
Kaur, Vikram Preet
Abdulqader, Mohammed Ali
Laller, Srishti
Datta, Abhigyan
Sheriff, Faisal
Rapisura, Mark
Singh, Gurinder
Martin, Mehwish
Urhoghide, Eseosa
Santos, Roberta
Lunagariya, Abhishek
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[3] Univ Missouri, Sch Med, Columbia, MO USA
[4] Geisinger Med Ctr, Danville, PA USA
[5] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[6] Maulana Azad Med Coll, New Delhi, India
[7] St Anthony Hosp, Chicago, IL USA
[8] Northridge Hosp Med Ctr, Northridge, CA USA
[9] Hialeah Hosp, Hialeah, FL USA
[10] Baylor St Lukes Med Ctr, CHI St Lukes Hlth, Houston, TX USA
[11] Hudson Reg Hosp, Secaucus, NJ USA
[12] Univ Cent Florida, COM HCA GME Consortium, Orlando, FL USA
来源：
STROKE | 2021年 / 52卷
关键词：
Metabolic syndrome; Atrial fibrillation; Ischemic stroke; Hyperlipidemia; Heart disease;
D O I：
10.1161/str.52.suppl_1.P712
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AP712
引用
收藏
页数：2
相关论文
共 50 条
  • [41] INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation
    Jee Eun Chung
    Yoo Ri Choi
    Jong Mi Seong
    Hyen O La
    Hye Sun Gwak
    International Journal of Clinical Pharmacy, 2015, 37 : 1038 - 1046
  • [42] Association of left atrial size with ischemic and bleeding risk scores in patients with non-valvular atrial fibrillation
    Enriquez-Rodriguez, E.
    Borrego-Bernabe, L.
    Espejo Paeres, A. C.
    Rueda-Linarez, A. C.
    Jimenez-Martin, M.
    Alcantar Fernandez, A. C.
    Perez-Villacastin, J.
    Macaya, C.
    Perez De Isla, L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 457 - 457
  • [43] Factors associated with elevated brain natriuretic peptide level in acute ischemic stroke patients with non-valvular atrial fibrillation
    Maruyama, K.
    Shiga, T.
    Ishizuka, K.
    Hoshino, T.
    Iijima, M.
    Uchiyama, S.
    Kitagawa, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 89 - 89
  • [44] THE DOSE OF DIRECT ORAL ANTICOAGULANTS AND STROKE SEVERITY IN PATIENTS WITH ACUTE ISCHEMIC STROKE AND NON-VALVULAR ATRIAL FIBRILLATION
    Kato, Y.
    Hayashi, T.
    Tanahashi, N.
    Takao, M.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 135 - 135
  • [45] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [46] Optimising stroke prevention in non-valvular atrial fibrillation
    Ederhy, Stephane
    Cohen, Ariel
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2079 - 2094
  • [47] CAUSES OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL-FIBRILLATION (NVAF)
    BOGOUSSLAVSKY, J
    VANMELLE, G
    REGLI, F
    KAPPENBERGER, L
    STROKE, 1990, 21 (01) : 174 - 174
  • [48] New Anticoagulants for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
    Hoecht, T.
    Frick, M.
    Alber, H.
    Huber, K.
    JOURNAL FUR KARDIOLOGIE, 2012, 19 (3-4): : 55 - 62
  • [49] EMBOLIC OR THROMBOTIC STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL-FIBRILLATION
    GUSTAFSSON, C
    BRITTON, M
    JOURNAL OF NEUROLOGY, 1985, 232 (03) : 199 - 199
  • [50] Timing of Anticoagulation After Stroke in Patients with Non-Valvular Atrial Fibrillation
    Sagalovich, Marina
    Osteraas, Nicholas
    Glover, Jon
    Dafer, Rima
    NEUROLOGY, 2021, 96 (15)
12345